Table 2.
IFN-γ levels from stimulated spleen T-cells taken four weeks after the third vaccination from five mice in each group
| Groups | IFN-γ levels (pg/ml, mean ± 1 SE) in response to: |
||||
|---|---|---|---|---|---|
| Ct-E EB | Ct-E-rMOMP | Concanavalin A | Medium | ||
| SPA08-1 | Vaccinated | 7,538 ± 817a | 15,563 ± 2,122a | 36,351 ± 5,933 | <15 |
| Control | <15 | <15 | 19,311 ± 2,492 | <15 | |
| SPA08-3 | Vaccinated | 2,748 ± 450a | 11,206 ± 404a | 45,599 ± 4,429 | <15 |
| Control | <15 | <15 | 43,226 ± 3,335 | <15 | |
| SPA08-4 | Vaccinated | 1,814 ± 1,837a | 5,416 ± 1,815a | 15,848 ± 1,669 | <15 |
| Control | <15 | <15 | 26,045 ± 2,965 | <15 | |
| APF | Vaccinated | 1,679 ± 265a | 1,166 ± 455a | 37,593 ± 1,558 | <15 |
| Control | <15 | <15 | 48,682 ± 1,284 | <15 | |
aP<0.05 by the Student’s t test compared to corresponding PBS control group.